Skip to main content
An array of prescription medications on shelves

Vaccines: A Case for Public Pharma

Expanding democratic ownership

Vaccines are critical to safeguarding public health as one of the most effective ways to prevent disease, including highly contagious diseases that can cause pandemics. But the for-profit pharmaceutical industry is neither prepared for nor incentivized to tackle growing public health challenges, like global pandemics.

The downloadable 1 page PDF below, produced in cooperation with the Center for Popular Democracy, makes the case for why we need public pharma to help combat pandemic threats like COVID-19.

Download and read now:

More related work

April 2, 2021
Illustration courtesy of United Nations

All health is public health: Busting the myths of choice and commodity

For decades, we have been sold a myth of private health. It is a myth that our health is largely a product of individual choices and personal responsibilities. It is a myth that our healthcare is a service that private corporations can provide, and for which we must pay to survive. But the COVID-19

read more
March 11, 2021
Mother and child during COVID-19. Photo by vperemen.com

One lesson a year of COVID-19 has taught us

For many people, the pandemic has ripped off the sunglasses that masked the true colors of our political economy. The question now is whether we will settle for a superficial and ephemeral recovery of the old system or use our capacity to build a new system.

read more
November 19, 2020
We can't wait to see you again (Nick Bolton/Unsplash)

Local economy preservation fund proposal goes to Biden administration

A plan for local economy preservation funds that would “save local businesses at scale” that would otherwise be casualties of the economic damage done by the CIVID-19 epidemic was delivered on November 19, 2020 to the Biden-Harris transition team by The Democracy Collaborative and the Council of

read more